TREATMENT OF FIBROBLAST GROWTH FACTOR 21 (FGF21) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO FGF21 Russian patent published in 2017 - IPC C12N15/113 A61K31/7088 A61K48/00 C12N15/63 

Abstract RU 2610661 C2

FIELD: biotechnology.

SUBSTANCE: described oligonucleotides, that increase expression of a gene of fibroblast growth factor 21 (FGF21), by interaction with the natural targeting antisense polynucleotides fibroblast growth factor 21 (FGF21). The present invention also relates to the use of the described oligonucleotides for the treatment of diseases and disorders associated with the expression of FGF21.

EFFECT: invention expands the arsenal of tools aimed for the treatment of diseases and disorders associated with the expression of FGF21.

26 cl, 2 dwg, 3 ex, 1 tbl

Similar patents RU2610661C2

Title Year Author Number
TREATMENT OF RNase H1 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO RNase H1 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2611192C2
TREATMENT DISEASES, ASSOCIATED WITH INTERFERON-REGULATORY FACTOR 8 (IRF8), BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRF8 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2611187C2
TREATMENT OF DISEASES CONNECTED WITH SITE-1 MEMBRANE-IMPACTED PEPTIDASE OF TRANSCRIPTION FACTORS (MBTPS1), BY INHIBITING NATURAL ANTISENSE TRANSCRIPT TO MBTPS1 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2639550C2
TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2611186C2
TREATMENT OF PYRROLINE-5-CARBOXYLATE REDUCTASE 1 (PYCR1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO PYCR1 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2608496C2
TREATMENT OF DISEASES, ASSOCIATED WITH SEX HORMONES BINDING GLOBULIN (SHBG), BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SHBG 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2611191C2
TREATMENT OF DISEASES ASSOCIATED WITH SUBSTRATE OF INSULIN RECEPTOR 2 (IRS2) BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2616283C2
TREATING DISEASES ASSOCIATED WITH NUCLEAR RESPIRATORY FACTOR 1 (NRF1) BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NRF1 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2615450C2
TREATMENT OF DISEASES ASSOCIATED WITH UNCOUPLING PROTEINS 2 (UCP2), BY INHIBITING OF NATURAL ANTISENSE TRANSCRIPT TO UCP2 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2619185C2
TREATMENT OF DISEASES, ASSOCIATED WITH HEPATOCYTE GROWTH FACTOR (HGF), BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO HGF 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2609631C2

RU 2 610 661 C2

Authors

Kollard Dzhozef

Khorkova Sherman Olga

Dates

2017-02-14Published

2011-04-08Filed